Details of Drug-Drug Interaction
| Drug General Information (ID: DDI4OEJ0UL) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Calcium glucoheptonate | Drug Info | Digitoxin | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Minerals And Electrolytes | Antiarrhythmic Agents | |||||||
| Structure | |||||||||
| Mechanism of Calcium glucoheptonate-Digitoxin Interaction (Severity Level: Major) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increased risk of other adverse reactions (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Calcium glucoheptonate | Digitoxin | |||||||
| Mechanism | Increase the arrhythmogenic effects of digitalis glycosides | Digitalis glycosides | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Adverse reactions | ||||||||
| Factor Description | An adverse reaction is an unexpected negative reaction to a medication or treatment that happens even when it's used correctly. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Intravenous calcium should preferably not be used in patients receiving digitalis glycosides, or it should be given slowly or in small amounts to avoid high serum calcium concentrations. Patients should be monitored for development of arrhythmias. | ||||||||
